Expertise in
1
conditions

Dr. James A. Welker

Internal Medicine
North Mississippi Medical Centers Rehabilitation Institute
830 S Gloster St, 
Tupelo, MS 
Accepting New Patients
Offers Telehealth
Expertise in
1
conditions
North Mississippi Medical Centers Rehabilitation Institute
830 S Gloster St, 
Tupelo, MS 

Overview

James Welker is a primary care provider, practicing in Internal Medicine in Tupelo, Mississippi.

Dr. Welker is highly rated in 1 condition, according to our data. His clinical expertise encompasses COVID-19, Pulmonary Embolism, Deep Vein Thrombosis, Gastrostomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 11 peer reviewed articles and participating in 6 clinical trials. Dr. Welker is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Internal Medicine in MD

Hospital Affiliations

North Mississippi Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Farm Bureau Health Plans
  • HMO
  • MEDICARE MAPD
  • MEDICARE PDP
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Magnolia Health
  • HMO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

North Mississippi Medical Centers Rehabilitation Institute
830 S Gloster St, Tupelo, MS 38801

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
CONSORTIUM - A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Multi-site, Phase III Study to Evaluate the Safety and Efficacy of CD24Fc in COVID-19 Treatment
A Randomized, Double-blind, Placebo-controlled, Multi-site, Phase III Study to Evaluate the Safety and Efficacy of CD24Fc in COVID-19 Treatment
Enrollment Status: Completed
Publish Date: February 08, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
A Phase 1b Randomized, Double-Blind, Placebo-Controlled, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy of SER-262 in Adults With Primary Clostridium Difficile Infection (CDI) to Prevent Recurrence
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Phase: Phase 1
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)
Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)
Enrollment Status: Completed
Publish Date: January 25, 2021
Intervention Type: Other
Study Phase: Not Applicable
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
RENal Hemodialysis Patients ALlocated Apixaban Versus Warfarin in Atrial Fibrillation (RENAL-AF) Randomized Clinical Trial
Enrollment Status: Completed
Publish Date: December 29, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

11 Total Publications

Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time.
Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time.
Journal: Journal of the American Heart Association
Published: December 11, 2025
Similar Doctors
Expertise in
22
conditions
Dr. Thomas D. Wooldridge
Internal Medicine
Expertise in
22
conditions
Dr. Thomas D. Wooldridge
Internal Medicine

Renal Care Group-Tupelo

2978 Mattox St, 
Tupelo, MS 
 (1.8 miles away)
662-844-0009
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Thomas Wooldridge is a primary care provider, practicing in Internal Medicine in Tupelo, Mississippi. Dr. Wooldridge is highly rated in 22 conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Frasier Syndrome, Endoscopy, and Colonoscopy. Dr. Wooldridge is currently accepting new patients.

Expertise in
38
conditions
Dr. Jayant Dey
Internal Medicine
Expertise in
38
conditions
Dr. Jayant Dey
Internal Medicine

North Mississippi Medical Center Services LLC

4250 S Eason Blvd, 
Tupelo, MS 
 (0.4 miles away)
662-377-6275
Languages Spoken:
English

Jayant Dey is a primary care provider, practicing in Internal Medicine in Tupelo, Mississippi. Dr. Dey is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Toxic Nodular Goiter, Thyroid Storm, Obesity in Children, and Vitamin D Deficiency.

Expertise in
21
conditions
Dr. William D. Mccomb
Internal Medicine
Expertise in
21
conditions
Dr. William D. Mccomb
Internal Medicine
Before you request

North Mississippi Medical Centers Rehabilitation Institute

830 S Gloster St, 
Tupelo, MS 
 (0.1 miles away)
662-377-2395
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

William Mccomb is a primary care provider, practicing in Internal Medicine in Tupelo, Mississippi. Dr. Mccomb is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Necrosis. Dr. Mccomb is currently accepting new patients.

Frequently Asked Questions about Dr. James A. Welker

How do I make an appointment with Dr. James A. Welker?

You can book an appointment with Dr. James A. Welker by calling their office at 662-377-3000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James A. Welker a top-rated expert for COVID-19?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James A. Welker is classified as an Advanced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James A. Welker specialize in?

While Dr. James A. Welker is a Internal Medicine, they have specific expertise in COVID-19, Pulmonary Embolism, and Deep Vein Thrombosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. James A. Welker participate in research or clinical trials?

Yes. Dr. James A. Welker has published 11 articles and abstracts on conditions like COVID-19. You can view a list of Dr. James A. Welker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James A. Welker accept my insurance?

Dr. James A. Welker accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 662-377-3000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Welker's expertise for a condition
ConditionClose
      View All 22 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile